Dice Therapeutics Inc (DICE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -83,887 | -48,959 | -23,739 | N/A | N/A |
| Depreciation Amortization | 3,025 | 768 | 697 | N/A | N/A |
| Accounts receivable | 1,500 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,334 | -772 | 1,411 | N/A | N/A |
| Other Working Capital | 2,643 | 1,647 | 1,663 | N/A | N/A |
| Other Operating Activity | 11,063 | 8,024 | -711 | 0 | 0 |
| Operating Cash Flow | $-64,322 | $-39,292 | $-20,679 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,237 | -718 | -148 | N/A | N/A |
| Purchase Of Investment | -139,252 | -218,471 | -3,649 | N/A | N/A |
| Sale Of Investment | 228,976 | 14,565 | 21,800 | N/A | N/A |
| Investing Cash Flow | $87,487 | $-204,624 | $18,003 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 2,416 | N/A | N/A | N/A |
| Debt Repayment | -2,644 | -99 | -122 | N/A | N/A |
| Common Stock Issued | 325,122 | 214,707 | N/A | N/A | N/A |
| Other Financing Activity | -226 | 83,230 | 54,017 | 0 | 0 |
| Financing Cash Flow | $322,252 | $300,254 | $53,895 | $N/A | $N/A |
| Beginning Cash Position | 116,174 | 59,836 | 8,617 | N/A | N/A |
| End Cash Position | 461,591 | 116,174 | 59,836 | N/A | N/A |
| Net Cash Flow | $345,417 | $56,338 | $51,219 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -64,322 | -39,292 | -20,679 | N/A | N/A |
| Capital Expenditure | -2,237 | -718 | -148 | N/A | N/A |
| Free Cash Flow | -66,559 | -40,010 | -20,827 | 0 | 0 |